🕒 Wednesday 1 April 2026 Wed, 1 Apr 2026

Empire Resources Limited has completed the issuance of 1 million shares under the second tranche of its placement, following shareholder approval at the recent extraordinary meeting. This move strengthens the company’s capital base as it pushes forward with its gold and copper projects in Western Australia.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for 30 of its ETFs for the March 2026 distribution period, with elections due by 7 April and unit issuance scheduled for 20 April.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for its Australian High Interest Cash ETF and Cash Plus Active ETF for the March 2026 distribution period. Investors must submit DRP elections by 7 April 2026, with unit issuance scheduled for 13 April.

Lithium Energy Limited has completed its initial drilling campaign at the Sandy Creek Prospect within Queensland’s Capricorn Gold-Copper Belt, with assay results expected in late May 2026. The company’s next steps hinge on these findings amid a region rich in historic mineralisation.

Healthscope has paid all rent due through April 2026 for hospitals owned by HealthCo Healthcare & Wellness REIT, while alternative operators submit plans to take over hospital operations.

Cauldron Energy Limited has clarified that its recent share price jump is driven by easing geopolitical tensions and a buoyant uranium market, with no undisclosed material information influencing trading.

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Acrow Limited has reported record new hire contracts and a robust sales pipeline, confirming FY26 guidance and issuing optimistic initial guidance for FY27 revenue and earnings.

CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.

Dome Gold Mines Ltd launches a $3 million convertible note offering to fund key developments in Fiji, including the Sigatoka Feasibility Study and expanded exploration for copper, gold, and silver.

Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

Cassius Mining’s Ghanaian subsidiary has escalated its damages claim to USD 905 million, citing lost profits from a stalled gold project, as the arbitration hearing looms in June.

Arovella Therapeutics has demonstrated that its novel CLDN18.2-targeting CAR incorporated into iNKT cells effectively eliminates pancreatic and gastric cancer cells in vitro, with IL-12-TM armouring enhancing potency and durability.

Red Sky Energy has secured its stake in the next phase of the Yarrow gas field development with Santos, backed by a $1 million placement and a planned Rights Issue to fund its share of the $2 million expenditure.

The High Court of Asturias has upheld a municipal council's procedural ruling against EMC Gold’s urban plan amendment for the Salave Gold Project, leaving the project’s technical merits untouched. EMC Gold signals ongoing stakeholder engagement and alternative development strategies ahead.

PT Aneka Tambang Tbk (ANTAM) reported a historic financial year in 2025, with revenue up 22% and net profit more than doubling to Rp7.92 trillion, driven by strong domestic demand and operational efficiency. The company also navigates evolving Indonesian mining regulations and ongoing legal challenges as it invests in downstream nickel projects.

Metgasco has ended its asset sale agreement with Vintage Energy after funding conditions were unmet, signaling a strategic pivot amid ongoing exploration and recapitalisation efforts.

Charger Metals NL advances its lithium and gold exploration with an expanded maiden resource at Medcalf and a striking high-grade gold discovery at Xmas. The company’s projects benefit from strong commodity prices and strategic locations in Australia’s premier mining jurisdictions.

Lindian Resources has raised A$100 million through an institutional placement, fully funding its Kangankunde Stage 1 project and accelerating Stage 2 expansion alongside downstream processing integration.

Dateline Resources has bolstered its financial position with a $50 million institutional placement, setting the stage for rapid development of its Colosseum Gold-REE Project in California. The company is on track to complete its Bankable Feasibility Study by April 2026, advancing towards production and project financing.

SQX Resources has reported impressive assay results from its maiden drilling at the Red Bird Gold Project in Arizona, revealing significant, shallow gold mineralisation with promising continuity. These findings bolster the project's potential for open-pit resource development.

Asara Resources reports strong drilling results at its Massan deposit within the Kada Gold Project, confirming continuity and extensions of high-grade gold mineralisation. The company advances its resource growth strategy with ongoing drilling and plans for a Mineral Resource Estimate update.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.